✦ LIBER ✦

Pharmacological evaluation of 1229U91, a high affinity and selective neuropeptide Y (NPY) - Y1 receptor antagonist

✍ Scribed by S.S. Hegde; D.W. Bonhaus; W. Stanley; R.M. Eglen; T.M. Moy; M. Loeb; S.G. Shetty; A. DeSouza; J. Krstenansky

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Neuropeptide Y Y1 Antagonist, 1229U9

✍ Douglas A Schober; Anne M Van Abbema; David L Smiley; Robert F Bruns; Donald R G 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Pharmacological characterization and sel

✍ Jessica E Matthews; Marilyn Jansen; Donald Lyerly; Richard Cox; Wen-Ji Chen; Ker 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 145 KB

BIIE0246: A selective and high affinity

✍ Henri Doods; Wolfram Gaida; Heike A Wieland; Horst Dollinger; Gerd Schnorrenberg 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 78 KB

GR231118 (1229U91) and other analogues o

✍ Eric M Parker; Carol K Babij; Ambikaipakan Balasubramaniam; Robert E Burrier; Ma 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 219 KB

A comparison of actions of neuropeptide

✍ M Smith-White; M.J Moriarty; E.K Potter 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 799 KB

Apparent affinity and potency of BIBP322

✍ Danielle Jacques; Alain Cadieux; Yvan Dumont; Rémi Quirion 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 207 KB